Atlas Trials

Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients

Clinical trial NCT03448744 · UNKNOWN

Trial details

NCT number
NCT03448744
Sponsor
Wen-hong Zhang
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis b
Start date
2017-10-25
Primary completion
2018-12-30
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.